Looping Amplification Primer Design for High-Level Multiplexing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Target re-sequencing in clinical research and disease diagnosis faces challenges with low target coverage, low sequencing specificity, and high costs due to limitations in increasing multiplexing levels beyond 10-plex, primarily due to primer dimer formation and reduced sequencing specificity.

Innovation Solution

A method involving the use of forward and reverse primers with target-specific and common sequences that form a stem-loop structure, allowing for the amplification of over 15,000 target nucleic acids per reaction in the Fluidigm ACCESS ARRAY system, utilizing on-chip barcoding and specific primer designs to enhance multiplexing without sacrificing sequencing specificity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If multiplexing level is increased beyond 10-plex, then more targets can be amplified per reaction, but primer dimer formation increases and sequencing specificity decreases

Engineering Contradiction:
Improvemultiplexing levelVSAvoidsequencing specificity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The primer is divided into distinct functional segments: a sample-specific portion for target recognition and a common sequence portion for amplification. This segmentation allows the sample-specific portion to be optimized for specificity while the common sequence enables efficient amplification, resolving the contradiction between multiplexing capacity and sequencing specificity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The common sequence portion serves multiple functions: it provides universal binding sites for amplification across all samples, enables standardized sequencing primer binding, and facilitates on-chip barcoding. This multi-functionality allows high multiplexing without sacrificing specificity, as the universal portion is designed to work consistently across all targets

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Productivity

If multiplexing level is increased, then more targets can be amplified per reaction, but cost decreases

Engineering Contradiction:
Improvemultiplexing levelVSAvoidcost
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

Multiple functions are merged into the primer design: sample identification, target amplification, and sequencing preparation are all integrated into a single primer component. This merging eliminates the need for separate barcoding steps and custom sequencing primers, reducing overall cost while enabling high multiplexing

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The common sequence portion is designed to be self-sufficient, providing all necessary binding sites and structural elements for amplification and sequencing without requiring additional reagents or components. This self-service design simplifies the workflow and reduces reagent costs, making high multiplexing economically viable

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly increases multiplexing levels while maintaining high sequencing specificity, enabling cost-effective and efficient targeted sequencing library preparation, allowing for the simultaneous amplification of thousands of targets with improved genomic coverage.

Implementation Method 1

a target nucleotide sequence is flanked by the common sequence on one end and its reverse complement on the other end, whereby a single strand of the target amplicon can form a stem loop structure

Methodology Applied
Scientific EffectStem-loop structure formation:

Data Source

PatentUS11857940B2High-level multiplex amplification
Publication Date: 2024.01.02 FLUIDING CORP
  • US11857940B2 patent drawing
  • US11857940B2 patent drawing
  • US11857940B2 patent drawing

AI summary

The present disclosure provides a “looping amplification” method to increase the specificity of nucleic acid amplification. This increased specificity facilitates multiplexing to a much higher degree than was previously possible.